Who Owns KZIA?

Kazia Therapeutics Limited — Institutional Ownership & 13F Holdings

$12.49

+0.23 (+1.88%)

Market Cap

$13.3M

Shares Outstanding

1,619,791

Institutional Holders

10

Total Inst. Value

$1.4M

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GAMMA Investing LLC$1.3M1,039
2BARCLAYS PLC$94K120,000
3UBS Group AG$21K26,285
4MAI Capital Management$3K3,854
5RHUMBLINE ADVISERS$1K1,911
6Arax Advisory Partners$7831,000
7OSAIC HOLDINGS, INC.$3950
8Allworth Financial LP$41
9WELLS FARGO & COMPANY/MN$34
10SIMPLEX TRADING, LLC$05

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
WELLS FARGO & COMPANY/MN+2$3

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold KZIA?

As of Q1 2025, 10 institutional investors report holding KZIA (Kazia Therapeutics Limited) in their 13F filings.

Which hedge fund owns the most KZIA?

The largest institutional holder of KZIA is GAMMA Investing LLC with $1.3M in shares.

Are institutions buying or selling KZIA?

This quarter, 3 institutions opened new positions in KZIA and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.